University of Minnesota. Driven to Discover.
Students have more than triple the risk of contracting serogroup B meningococcal disease.
A survey of primary care docs reveals significant gaps in their knowledge of serogroup B meningococcal vaccines.
Panel gives a preference to Shingrix and recommends MMR for mumps outbreaks.
The vaccine protected 78% of newborns from pertussis and 90% from hospitalized cases.
Only 54% of US workers with asthma had received the recommended pneumococcal vaccine.
"It would be a mistake to divert important resources during this time toward tetanus vaccination."
Vaccines are unavailable at least once a month, and 19% to 38% of shipments have temperature issues.
Most recipients produced antibodies, but 34% had no immune response to the outbreak strain.
Money could come from governments, industry, and others, with grants monitored by independent groups.
ACIP stops short of recommending routine use of group B vaccine in young people.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.